Monashee Investment Management
Latest statistics and disclosures from Monashee Investment Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are GPCR, MDLN, SOFI, ULS, INSM, and represent 32.50% of Monashee Investment Management's stock portfolio.
- Added to shares of these 10 stocks: MDLN (+$13M), SOFI (+$11M), ULS (+$10M), INSM (+$8.7M), TERN (+$8.0M), KYMR (+$7.8M), SLDB (+$7.6M), IMNM (+$5.9M), ITT (+$5.6M), WLTH.
- Started 28 new stock positions in KYTX, GOSS, TARA, INSM, ITT, KYMR, NKTR, DYN, SOFI, EVMN.
- Reduced shares in these 10 stocks: FWDI (-$10M), BBIO (-$7.6M), FIGR (-$7.3M), NTSK (-$6.8M), CRBG (-$6.4M), LTM (-$6.1M), WBI (-$6.1M), WAY (-$5.7M), BTBT, .
- Sold out of its positions in AIRO, AMLX, RNA, BRCB, BRKRP, CTRE, CARL, CHYM, CIFR, CRCL.
- Monashee Investment Management was a net seller of stock by $-37M.
- Monashee Investment Management has $178M in assets under management (AUM), dropping by -11.51%.
- Central Index Key (CIK): 0001627608
Tip: Access up to 7 years of quarterly data
Positions held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Monashee Investment Management
Monashee Investment Management holds 40 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Structure Therapeutics Sponsored Ads (GPCR) | 8.8 | $16M | +12% | 225k | 69.55 |
|
| Medline Com Cl A (MDLN) | 7.1 | $13M | NEW | 300k | 42.00 |
|
| Sofi Technologies (SOFI) | 5.9 | $11M | NEW | 400k | 26.18 |
|
| Ul Solutions Class A Com Shs (ULS) | 5.8 | $10M | NEW | 130k | 78.86 |
|
| Insmed Com Par $.01 (INSM) | 4.9 | $8.7M | NEW | 50k | 174.04 |
|
| Terns Pharmaceuticals (TERN) | 4.5 | $8.0M | NEW | 197k | 40.40 |
|
| Kymera Therapeutics (KYMR) | 4.4 | $7.8M | NEW | 100k | 77.81 |
|
| Miami Intl Hldgs (MIAX) | 4.4 | $7.8M | +16% | 175k | 44.38 |
|
| Bridgebio Pharma (BBIO) | 4.3 | $7.6M | -50% | 100k | 76.49 |
|
| Solid Biosciences Com New (SLDB) | 4.3 | $7.6M | NEW | 1.3M | 5.64 |
|
| Legence Corp Cl A (LGN) | 3.3 | $5.9M | -8% | 138k | 43.04 |
|
| Immunome (IMNM) | 3.3 | $5.9M | NEW | 275k | 21.48 |
|
| Itt (ITT) | 3.1 | $5.6M | NEW | 32k | 173.51 |
|
| Compass Therapeutics (CMPX) | 3.0 | $5.4M | -20% | 1.0M | 5.37 |
|
| Cytokinetics Com New (CYTK) | 2.7 | $4.8M | -25% | 75k | 63.54 |
|
| Wealthfront Corp (WLTH) | 2.3 | $4.1M | NEW | 300k | 13.59 |
|
| Nektar Therapeutics Com New (NKTR) | 2.2 | $4.0M | NEW | 94k | 42.28 |
|
| Southern Unit 12/15/2028 (SOMN) | 2.2 | $3.8M | NEW | 76k | 50.36 |
|
| Adt (ADT) | 1.8 | $3.2M | -11% | 400k | 8.07 |
|
| Evommune Com Shs (EVMN) | 1.8 | $3.1M | NEW | 183k | 17.12 |
|
| Gossamer Bio (GOSS) | 1.7 | $3.1M | NEW | 1.0M | 3.10 |
|
| Novanta Unit 11/01/2028 (NOVTU) | 1.7 | $3.1M | NEW | 56k | 54.98 |
|
| Lumexa Imaging Holdings (LMRI) | 1.6 | $2.8M | NEW | 150k | 18.50 |
|
| Engene Holdings (ENGN) | 1.5 | $2.7M | NEW | 295k | 9.03 |
|
| Ambiq Micro Common Stock (AMBQ) | 1.4 | $2.4M | -57% | 85k | 28.50 |
|
| Dyne Therapeutics (DYN) | 1.3 | $2.2M | NEW | 115k | 19.56 |
|
| Whitefiber SHS (WYFI) | 1.2 | $2.2M | -60% | 140k | 15.80 |
|
| Grupo Aeromexico Sab De Cv Sponsored Ads (AERO) | 1.1 | $2.0M | NEW | 92k | 21.96 |
|
| Eqv Ventures Ac Corp. Ii Unit 06/30/2032 (EVAC.U) | 1.1 | $2.0M | -11% | 198k | 10.11 |
|
| Kyverna Therapeutics (KYTX) | 1.0 | $1.8M | NEW | 195k | 9.40 |
|
| Immatics SHS (IMTX) | 0.9 | $1.7M | NEW | 160k | 10.50 |
|
| Contineum Therapeutics Cl A (CTNM) | 0.9 | $1.6M | NEW | 137k | 11.43 |
|
| Denali Therapeutics (DNLI) | 0.9 | $1.5M | NEW | 92k | 16.51 |
|
| Gossamer Bio Note 5.000% 6/0 (Principal) | 0.7 | $1.3M | +87% | 1.9M | 0.68 |
|
| Vera Therapeutics Cl A (VERA) | 0.7 | $1.2M | NEW | 23k | 50.64 |
|
| Lightpath Technologies Com Cl A (LPTH) | 0.6 | $1.1M | NEW | 100k | 10.80 |
|
| Biodesix (BDSX) | 0.4 | $764k | +12% | 112k | 6.80 |
|
| Protara Therapeutics Com Stk (TARA) | 0.4 | $666k | NEW | 125k | 5.33 |
|
| Imagenebio (IMA) | 0.4 | $632k | NEW | 92k | 6.90 |
|
| Ibio Com New (IBIO) | 0.3 | $531k | NEW | 275k | 1.93 |
|
Past Filings by Monashee Investment Management
SEC 13F filings are viewable for Monashee Investment Management going back to 2015
- Monashee Investment Management 2025 Q4 filed Feb. 12, 2026
- Monashee Investment Management 2025 Q3 filed Nov. 12, 2025
- Monashee Investment Management 2025 Q2 filed Aug. 11, 2025
- Monashee Investment Management 2025 Q1 filed May 14, 2025
- Monashee Investment Management 2024 Q4 filed Feb. 14, 2025
- Monashee Investment Management 2024 Q3 filed Nov. 12, 2024
- Monashee Investment Management 2024 Q2 filed Aug. 12, 2024
- Monashee Investment Management 2024 Q1 filed May 14, 2024
- Monashee Investment Management 2023 Q4 filed Feb. 12, 2024
- Monashee Investment Management 2023 Q3 filed Nov. 13, 2023
- Monashee Investment Management 2023 Q2 filed Aug. 10, 2023
- Monashee Investment Management 2023 Q1 filed May 5, 2023
- Monashee Investment Management 2022 Q4 filed Feb. 9, 2023
- Monashee Investment Management 2022 Q3 filed Nov. 1, 2022
- Monashee Investment Management 2022 Q2 filed Aug. 12, 2022
- Monashee Investment Management 2022 Q1 filed May 12, 2022